Evidence map›Paper›PMID 22644988›Full record

ArticleMolecular imaging and biology2013

Reproducibility of static and dynamic (18)F-FDG, (18)F-FLT, and (18)F-FMISO MicroPET studies in a murine model of HER2+ breast cancer.

Jennifer G Whisenant, Todd E Peterson, Jacob U Fluckiger, Mohammed Noor Tantawy, Gregory D Ayers, Thomas E Yankeelov

Abstract read
In one paragraph

Article in Molecular imaging and biology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Repeatability of tumour hypoxia imaging using [European journal of nuclear medicine and molecular imaging · 2018
    Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Noninvasive evaluation ofScientific reports · 2018
    Article
  7. Quantitative [Molecular imaging and biology · 2017
    Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Kinetic modeling in PET imaging of hypoxia.American journal of nuclear medicine and molecular imaging · 2014
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Jennifer G WhisenantInstitute of Imaging Science, Vanderbilt University Medical Center, 1161 21st Ave. South, MCN AA-1105, Nashville, TN 37232-2675, USA.
Todd E Peterson
Jacob U Fluckiger
Mohammed Noor Tantawy
Gregory D Ayers
Thomas E Yankeelov

Funding

Tumor Immunology and Microenvironment Research ProgramP30CA068485 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI MATTHEW J TYSKA · 1995 to 2026
$172.8M
TISSUE CoreP50CA098131 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI PARK, BEN HO, PIETENPOL, JENNIFER A · 2003 to 2024
$48.7M
Vanderbilt In Vivo Cellular and Molecular Imaging CenterP50CA128323 · NCI · VANDERBILT UNIVERSITY · PI SHYR, YU · 2008 to 2012
$6.8M
Evaluation and Validation of Imaging Biomarkers of Tumor Response to TreatmentR01CA138599 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI MCINTYRE, JAMES OLIVER · 2010 to 2015
$2.2M
South-Eastern Center for Imaging Animal Models of CancerU24CA126588 · NCI · VANDERBILT UNIVERSITY · PI GORE, JOHN C · 2007 to 2011
$2.1M
Small Animal PET ScannerS10RR017858 · NCRR · VANDERBILT UNIVERSITY · PI KESSLER, ROBERT MICHAEL · 2003 to 2003
$500k
NCI NIH HHS P30 CA068485NCI NIH HHS P30 CA68485NCI NIH HHS P50 CA098131NCI NIH HHS P50 CA12832NCI NIH HHS P50 CA128323NCI NIH HHS P50 CA98131NCI NIH HHS R01 CA138599NCI NIH HHS U24 CA126588NCRR NIH HHS 1 S10 RR17858NCRR NIH HHS S10 RR017858
6 · The paper itself

Abstract

purposeThe objective of this study is to determine the reproducibility of static 2-deoxy-2-[(18)F]fluoro-D-glucose ((18)F-FDG), 3'-deoxy-3'-[(18)F]fluorothymidine ((18)F-FLT), and [(18)F]-fluoromisonidazole ((18)F-FMISO) microPET measurements, as well as kinetic parameters returned from analyses of dynamic (18)F-FLT and (18)F-FMISO data. PROCEDURES: HER2+ xenografts were established in nude mice. Dynamic data were acquired for 60 min, followed by a repeat injection and second scan 6 h later. Reproducibility was assessed for the percent-injected dose per gram (%ID/g) for each radiotracer, and with kinetic parameters (K (1) -k (4) , K ( i )) for (18)F-FLT and (18)F-FMISO.

resultsThe value needed to reflect a change in tumor physiology is given by the 95 % confidence interval (CI), which is ±14, ±5, and ±6 % for (18)F-FDG (n = 12), (18)F-FLT (n = 11), and (18)F-FMISO (n = 11) %ID/g, respectively. V ( d ) (=K (1) /k (2)), k (3), and K (FLT) are the most reproducible (18)F-FLT (n = 9) kinetic parameters, with 95 % CIs of ±18, ±10, and ±18 %, respectively. V ( d ) and K (FMISO) are the most reproducible (18)F-FMISO kinetic parameters (n = 7) with 95 % CIs of ±16 and ±14 %, respectively.

conclusionsPercent-injected dose per gram measurements are reproducible and appropriate for detecting treatment-induced changes. Kinetic parameters have larger threshold values, but are potentially sufficiently reproducible to detect treatment response.

Indexed as

DideoxynucleosidesFluorodeoxyglucose F18RadiopharmaceuticalsAnimalsErb-b2 Receptor Tyrosine KinasesFemaleHumansKineticsMammary Neoplasms, ExperimentalMiceMice, NudeMisonidazoleModels, BiologicalMolecular ImagingPositron-Emission TomographyReproducibility of ResultsalovudineDideoxynucleosidesErb-b2 Receptor Tyrosine KinasesFluorodeoxyglucose F18fluoromisonidazoleMisonidazoleRadiopharmaceuticals

Identifiers

PMID22644988
PMCPMC3752931

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.